lipidemia, and
coronary artery disease.
Outcomes at 30 days. CEA was associated with a signiﬁcant reduction in stroke and a signiﬁcant increase in
the risk of MI at 30 days compared with CAS (7 studies;
RR, 0.60; 95% CI, 0.42-0.86; Fig 1) and (6 studies; RR,
2.15; 